Business Opportunities

Oil weakens in Asian trade on profit-taking

Oil fell in Asian trade today on profit-taking after overnight gains driven by hopes for improved demand as the global economy recovers, analysts said. - Festive season fails to revive paint sales - Oil rises above $72 ahead of US company results - Oil prices fall to $71 in opening trade - Oil rebounds in Asia as US aluminium giant posts profit - Oil extends gains on dollar weakness - Kuwait sees no change in OPEC output this year New York"s main contract, light sweet crude for November, delivery fell 41 cents to $72.86 a barrel. Brent North Sea crude for November delivery sank 22 cents to $71.14. "Coming off recent highs, the only thing I would note is with prices getting to $73, that might have encouraged some profit-taking," said David Moore, a Sydney-based commodity strategist with the Commonwealth Bank of Australia. Looking ahead, the under-performing US dollar is likely to remain a big influence in driving crude prices higher, Moore said. "I think the fragility of the US dollar has been a supporting factor," he said. A struggling greenback tends to boost crude prices particularly because the dollar-denominated commodity becomes cheaper for foreign buyers holding stronger currencies. The US currency had come under pressure recently from speculation that the United States would be slower to tighten monetary policy than other central banks. Rod Smyth at Riverfront Investment Group said the Fed is still flooding the market with dollars, making it hard to increase the value of the greenback. "As long as the Federal Reserve continues to print money, we think the dollar will weaken and risk assets around the world will benefit," he said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Karbonn leaves its print on the handset market
Hopes to capture 7-10% share of the multimedia segment.
Popular Articles

Sun gets support of RMG in battle against Taro
Sun Pharmaceutical Industries’ attempts to take over Israeli drug major Taro Pharmaceutical is gaining more support from independent advisory firms. RiskMetrics Group’s ISS Governance Services (RMG), an independent proxy advisory firm, has recommended that shareholders of Taro Pharmaceutical Industries vote against all the proposals made by Taro’s board of directors, including all of its nominees for election and re-election as directors in the upcoming Annual General Meeting (AGM) scheduled for December 31, Sun Pharma said in a press release.

Investment committee to submit report by Sep-end
The committee set up to look into the issue of regulating investment advice would submit its report to the government by the month end.